| PA | Pseudomonas aeruginosa |
| C-T | Ceftolozane-tazobactam |
| MSMC | The HRH Princess Maha Chakri Sirindhorn Medical Center |
| MIC | The minimal inhibitory concentration |
| MDR | Multidrug-resistant |
| XDR | Extremely drug-resistant |
| PDR | Pan-drug resistant |
| CRPA | Carbapenem-resistant Pseudomonas aeruginosa |
| CDC | Center––of Disease Control and Prevention |
| NARST | National Nosocomial Resistance Surveillance, Thailand |
| PCR | Polymerase Chain Reaction |
| SMART | Global Study for Monitoring Antimicrobial Resistance Trends |
| ST | Sequence type |
| CIP | Ciprofloxacin |
| CAZ | Ceftazidime |
| TZP | Piperacillin-tazobactam |
| ATM | Aztreonam |
| MEM | Meropenem |
| IPM | Imipenem |
| AMK | Amikacin |
| GEN | Gentamicin |
| TOB | Tobramycin |
| CST | Colistin |
| S | Susceptible |
| I | Intermediate |
| R | Resistance |